Biomarker-driven therapy (unspecified agent)

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biomarker-driven therapy (unspecified agent), covering 2020-07-24 to 2020-07-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) [Phase 2]